Eli Lilly to boost output of weight loss, diabetes, Alzheimer’s drugs

Eli Lilly to boost output of weight loss, diabetes, Alzheimer’s drugs

A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024. Scott Olson | Getty Images Eli Lilly on Thursday said it will invest $1.8 billion to boost manufacturing for its newly approved Alzheimer’s drug and highly popular weight loss and diabetes treatments, among other medicines, … Read more

$1 billion in cost cuts, 10 product launches planned

 billion in cost cuts, 10 product launches planned

Moderna headquarters, exterior view, Cambridge, Massachusetts, USA.  Plexi Images | GHI | UCG | Universal Images Group | Getty Images Moderna on Thursday said it plans to cut around $1.1 billion in expenses by 2027 and win approvals for several new products as it charts a path forward after the rapid decline of its Covid business.  … Read more

57 million privately insured adults eligible for GLP-1s

57 million privately insured adults eligible for GLP-1s

Weight loss syringes of the brands “Wegovy”, “Ozempic” and “Mounjaro” are sold at In der Achat Apotheke in Mitte, Germany. Picture Alliance | Picture Alliance | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future … Read more

AstraZeneca shares fall 5% on disappointing lung cancer drug trial

AstraZeneca shares fall 5% on disappointing lung cancer drug trial

An illustrative image of a person holding a medical syringe and a Covid-19 vaccine vial in front of the the AstraZeneca logo displayed on a screen. On Wednesday, January 12, 2021, in Edmonton, Alberta, Canada. (Photo by Artur Widak/NurPhoto via Getty Images) Nurphoto | Nurphoto | Getty Images AstraZeneca shares fell more than 5% Tuesday … Read more

Leqembi could give Alzheimer’s patients more time, but road to treatment is long

Leqembi could give Alzheimer’s patients more time, but road to treatment is long

Hannah Yoon | The Washington Post | Getty Images Leqembi, an Alzheimer’s drug from Biogen and Eisai, isn’t a cure for the mind-damaging disease.  But the treatment promises to give patients such as Missie Meeks more time to live their daily lives normally and independently of others. Meeks, an English professor based in Ellisville, Mississippi, … Read more

Eli Lilly could become the first $1 trillion healthcare stock

Eli Lilly could become the first  trillion healthcare stock

A sign with the company logo outside the headquarters of Eli Lilly and Company in Indianapolis, Indiana, March 17, 2024. Scott Olson | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Earlier this … Read more

AstraZeneca staff detained in China amid reported drug-import probe

AstraZeneca staff detained in China amid reported drug-import probe

The office building of biopharmaceutical company AstraZeneca is being seen in Shanghai, China, on May 23, 2024.  Nurphoto | Getty Images Some employees of British pharmaceutical giant AstraZeneca have been detained by police in China as part of an investigation, the company confirmed Thursday. “We are aware a small number of our employees in China … Read more

FDA authorizes Novavax Covid vaccine targeting JN.1

FDA authorizes Novavax Covid vaccine targeting JN.1

A vial labelled “Novavax V COVID-19 Vaccine” is seen in this illustration taken January 16, 2022.  Dado Ruvic | Reuters The Food and Drug Administration authorized Novavax‘s updated protein-based Covid vaccine for emergency use in people ages 12 and up on Friday, paving the way for the shot to compete with Pfizer and Moderna‘s jabs … Read more

New Covid shots from Pfizer, Moderna, what to know

New Covid shots from Pfizer, Moderna, what to know

Moderna Covid-19 Vaccine mRNA 2024-2025 formula. Courtesy: Moderna A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. It’s that time of the year again. A new round of Covid shots is on its way to Americans.  … Read more

Eli Lilly releases new, cheaper form of weight loss drug

Eli Lilly releases new, cheaper form of weight loss drug

An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023. Brendan McDermid | Reuters Eli Lilly on Tuesday released a new form of its weight loss drug Zepbound for roughly half its usual monthly list price to reach millions of patients without insurance coverage for … Read more